These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 2678817)
1. [Psychopathology and performance behavior in anticonvulsant treatment of children and adolescents]. Blank R Z Kinder Jugendpsychiatr; 1989 Sep; 17(3):140-9. PubMed ID: 2678817 [No Abstract] [Full Text] [Related]
2. Carbamazepine treatment of epileptic and psychic symptoms in children and adolescents. Donner M; Frisk M Ann Paediatr Fenn; 1965; 11(2):91-7. PubMed ID: 4955094 [No Abstract] [Full Text] [Related]
3. Effect of folate metabolism on the psychopathology of adults with mental retardation and epilepsy. Deb S Am J Ment Retard; 1994 May; 98(6):717-23. PubMed ID: 8054200 [TBL] [Abstract][Full Text] [Related]
4. [The use of anticonvulsant treatment of behaviorally disturbed children with bio-electric epilepsy. A follow-up study of 76 cases (author's transl)]. Egli M; Graf I Acta Paedopsychiatr; 1975; 41(2):54-69. PubMed ID: 1108592 [No Abstract] [Full Text] [Related]
5. Clonazepam--a clinical study of its effectiveness as an anticonvulsant. Edwards VE; Eadie MJ Proc Aust Assoc Neurol; 1973; 10(0):61-6. PubMed ID: 4600355 [No Abstract] [Full Text] [Related]
6. [Epilepsy, anticonvulsive treatment and child psychiatric conspicuousness]. Lehmkuhl G; Detzner M; Poustka F Z Kinder Jugendpsychiatr; 1985; 13(3):199-211. PubMed ID: 3837567 [TBL] [Abstract][Full Text] [Related]
7. [The effect of valproic acid monotherapy on behavior and cognitive performance of children with idiopathic generalized epilepsy]. Schmidt A; Darius J; Brosz M; Roth N; Meyer FP; Kroker S; Wien F; Brett B Z Kinder Jugendpsychiatr; 1995 Sep; 23(3):161-70. PubMed ID: 7571875 [TBL] [Abstract][Full Text] [Related]
8. Antiepileptic drug trials in children and adolescents: is there a need? Buchhalter JR Adv Neurol; 1998; 76():161-5. PubMed ID: 9408473 [No Abstract] [Full Text] [Related]
9. [Study of the effects of Tegretol on a population of epileptic children]. Martin F; Movarrekhi M; Gisiger MG Schweiz Med Wochenschr; 1965 Jul; 95(29):982-9. PubMed ID: 5319730 [No Abstract] [Full Text] [Related]
10. The use of clonazepam as an anticonvulsant--clinical evaluation. Bladin PF Med J Aust; 1973 Apr; 1(14):683-8. PubMed ID: 4633863 [No Abstract] [Full Text] [Related]
11. Epilepsy in children and adolescents. Thiele EA; Gonzalez-Heydrich J; Riviello JJ Child Adolesc Psychiatr Clin N Am; 1999 Oct; 8(4):671-94. PubMed ID: 10553198 [TBL] [Abstract][Full Text] [Related]
12. [Encephalopathies related to the incidence of seizures in anticonvulsive therapy]. Todt H; Sachs B Kinderarztl Prax; 1987 Sep; 55(9):437-41. PubMed ID: 3682596 [No Abstract] [Full Text] [Related]
13. [Clinical-encephalographic evaluation of new anticonvulsant drugs with "double blind" technic]. Turner M; Jaen L; Alvarez R Arch Argent Pediatr; 1964 Jun; 61(6):282-7. PubMed ID: 4378501 [No Abstract] [Full Text] [Related]
14. The management of epilepsy in children: cognitive and behavioral side effects. Nordli DR Rev Neurol Dis; 2004; 1 Suppl 1():S4-9. PubMed ID: 16400289 [TBL] [Abstract][Full Text] [Related]
15. Clinical experience with anticonvulsant medication in pediatric epilepsy and comorbid bipolar spectrum disorder. Salpekar JA; Conry JA; Doss W; Cushner-Weinstein S; Pearl PL; Weinstein SL; Gaillard WD Epilepsy Behav; 2006 Sep; 9(2):327-34. PubMed ID: 16861047 [TBL] [Abstract][Full Text] [Related]
16. [Factors to consider in the evaluation of intellectual achievement of an epileptic child]. Pestana EM; Sardiñas N; Trujillo C Rev Neurol; 1997 Aug; 25(144):1225-8. PubMed ID: 9340156 [TBL] [Abstract][Full Text] [Related]
17. [Selecting the first drug in children and adolescents with epilepsy: evidence versus personal experience]. Herranz JL Rev Neurol; 2012 May; 54 Suppl 3():S1-5. PubMed ID: 22605626 [TBL] [Abstract][Full Text] [Related]
18. [Cognitive impairment in childhood epilepsy: the role of antiepileptic drugs]. Tich SN; Péréon Y Epileptic Disord; 2001; 3 Spec No 2():SI87-93. PubMed ID: 11827851 [TBL] [Abstract][Full Text] [Related]
19. Significant anticonvulsant side-effects in children and adolescents. Harbord MG J Clin Neurosci; 2000 May; 7(3):213-6. PubMed ID: 10833618 [TBL] [Abstract][Full Text] [Related]
20. [Administration of 25-hydroxyvitamin D3 for the prevention of disorders of calcium-phosphate metabolism after anticonvulsant therapy in children]. Rowińska E; Pronicka E; Chmielik J; Jelonek A; Wieczorek E; Lorenc R Pediatr Pol; 1986 Jul; 61(7):415-20. PubMed ID: 3822605 [No Abstract] [Full Text] [Related] [Next] [New Search]